SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nadeeka N.W. Dissanayaka, Elizabeth White, John D. O'Sullivan, Rodney Marsh, Peter A. Silburn, David A. Copland, George D. Mellick, Gerard J. Byrne, Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease, Movement Disorders Clinical Practice, 2015, 2, 1
  2. 2
    Alanna Dancis, Valerie T. Cotter, Diagnosis and Management of Cognitive Impairment in Parkinson’s Disease, The Journal for Nurse Practitioners, 2015, 11, 3, 307

    CrossRef

  3. 3
    Maritza Sandoval-Rincón, Michel Sáenz-Farret, Adán Miguel-Puga, Federico Micheli, Oscar Arias-Carrión, Rational Pharmacological Approaches for Cognitive Dysfunction and Depression in Parkinson’s Disease, Frontiers in Neurology, 2015, 6,

    CrossRef

  4. 4
    H. C. V. Pfeiffer, A. Løkkegaard, M. Zoetmulder, L. Friberg, L. Werdelin, Cognitive impairment in early-stage non-demented Parkinson's disease patients, Acta Neurologica Scandinavica, 2014, 129, 5
  5. 5
    Roberta Biundo, Luca Weis, Silvia Facchini, Patrizia Formento-Dojot, Annamaria Vallelunga, Manuela Pilleri, Angelo Antonini, Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia, Parkinsonism & Related Disorders, 2014, 20, 4, 394

    CrossRef

  6. 6
    Zhong Zheng, Shirag Shemmassian, Christopher Wijekoon, Won Kim, Susan Y. Bookheimer, Nader Pouratian, DTI correlates of distinct cognitive impairments in Parkinson's disease, Human Brain Mapping, 2014, 35, 4
  7. 7
    Javier Pagonabarraga, Carles Soriano-Mas, Gisela Llebaria, Marina López-Solà, Jesús Pujol, Jaime Kulisevsky, Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 3, 290

    CrossRef

  8. 8
    Alberto Costa, Eriola Bagoj, Marco Monaco, Silvia Zabberoni, Salvatore De Rosa, Anna Maria Papantonio, Ciro Mundi, Carlo Caltagirone, Giovanni Augusto Carlesimo, Standardization and normative data obtained in the Italian population for a new verbal fluency instrument, the phonemic/semantic alternate fluency test, Neurological Sciences, 2014, 35, 3, 365

    CrossRef

  9. 9
    Ulla Ellfolk, Juho Joutsa, Juha O. Rinne, Riitta Parkkola, Pekka Jokinen, Mira Karrasch, Striatal volume is related to phonemic verbal fluency but not to semantic or alternating verbal fluency in early Parkinson’s disease, Journal of Neural Transmission, 2014, 121, 1, 33

    CrossRef

  10. 10
    Jennifer G. Goldman, Caroline Williams-Gray, Roger A. Barker, John E. Duda, James E. Galvin, The spectrum of cognitive impairment in Lewy body diseases, Movement Disorders, 2014, 29, 5
  11. 11
    Connie Marras, Alexander I. Tröster, Jaime Kulisevsky, Glenn T. Stebbins, The tools of the trade: A state of the art “How to Assess Cognition” in the patient with Parkinson's disease, Movement Disorders, 2014, 29, 5
  12. 12
    Elizabeth L. Stegemöller, Joe Nocera, Irene Malaty, Mack Shelley, Michael S. Okun, Chris J. Hass, Timed Up and Go, Cognitive, and Quality-of-Life Correlates in Parkinson's Disease, Archives of Physical Medicine and Rehabilitation, 2014, 95, 4, 649

    CrossRef

  13. 13
    Gabriella Santangelo, Paolo Barone, Giovanni Abbruzzese, Luigi Ferini-Strambi, Angelo Antonini, Validation of the Italian version of Parkinson’s Disease-Cognitive Rating Scale (PD-CRS), Neurological Sciences, 2014, 35, 4, 537

    CrossRef

  14. 14
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, A. Sesar, F. Valldeoriola-Serra, R. Yañez, Advanced Parkinson's disease: Clinical characteristics and treatment (part 1), Neurología (English Edition), 2013, 28, 8, 503

    CrossRef

  15. 15
    Rachel Tabak, Gwendolyne Aquije, Beth E. Fisher, Aerobic Exercise to Improve Executive Function in Parkinson Disease, Journal of Neurologic Physical Therapy, 2013, 37, 2, 58

    CrossRef

  16. 16
    Kim T.E. Olde Dubbelink, Diederick Stoffers, Jan Berend Deijen, Jos W.R. Twisk, Cornelis J. Stam, Henk W. Berendse, Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study, Neurobiology of Aging, 2013, 34, 2, 408

    CrossRef

  17. 17
    M. Zarei, N. Ibarretxe-Bilbao, Y. Compta, M. Hough, C. Junque, N. Bargallo, E. Tolosa, M. J. Marti, Cortical thinning is associated with disease stages and dementia in Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, 2013, 84, 8, 875

    CrossRef

  18. 18
    Jennifer G. Goldman, Samantha Holden, Bryan Bernard, Bichun Ouyang, Christopher G. Goetz, Glenn T. Stebbins, Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease, Movement Disorders, 2013, 28, 14
  19. 19
    Roberta Biundo, Luca Weis, Manuela Pilleri, Silvia Facchini, Patrizia Formento-Dojot, Annamaria Vallelunga, Angelo Antonini, Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson’s disease, Journal of Neural Transmission, 2013, 120, 4, 627

    CrossRef

  20. You have free access to this content20
    A. Berardelli, G. K. Wenning, A. Antonini, D. Berg, B. R. Bloem, V. Bonifati, D. Brooks, D. J. Burn, C. Colosimo, A. Fanciulli, J. Ferreira, T. Gasser, F. Grandas, P. Kanovsky, V. Kostic, J. Kulisevsky, W. Oertel, W. Poewe, J.-P. Reese, M. Relja, E. Ruzicka, A. Schrag, K. Seppi, P. Taba, M. Vidailhet, EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  21. 21
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, A. Sesar, F. Valldeoriola-Serra, R. Yañez, Enfermedad de Parkinson avanzada. Características clínicas y tratamiento (parte I), Neurología, 2013, 28, 8, 503

    CrossRef

  22. 22
    Jaime Kulisevsky, Ramón Fernández de Bobadilla, Javier Pagonabarraga, Saül Martínez-Horta, Antonia Campolongo, Carmen García-Sánchez, Berta Pascual-Sedano, Roser Ribosa-Nogué, Carolina Villa-Bonomo, Measuring functional impact of cognitive impairment: Validation of the Parkinson's Disease Cognitive Functional Rating Scale, Parkinsonism & Related Disorders, 2013, 19, 9, 812

    CrossRef

  23. 23
    Connie Marras, Melissa J. Armstrong, Christopher A. Meaney, Susan Fox, Brandon Rothberg, William Reginold, David F. Tang-Wai, David Gill, Paul J. Eslinger, Cindy Zadikoff, Nancy Kennedy, Fred J. Marshall, Mark Mapstone, Kelvin L. Chou, Carol Persad, Irene Litvan, Benjamin T. Mast, Adam T. Gerstenecker, Sandra Weintraub, Sarah Duff-Canning, Measuring mild cognitive impairment in patients with Parkinson's disease, Movement Disorders, 2013, 28, 5
  24. 24
    Alberto Costa, Eriola Bagoj, Marco Monaco, Silvia Zabberoni, Salvatore De Rosa, Ciro Mundi, Carlo Caltagirone, Giovanni Augusto Carlesimo, Mini mental Parkinson test: standardization and normative data on an Italian sample, Neurological Sciences, 2013, 34, 10, 1797

    CrossRef

  25. 25
    Ramón Fernández de Bobadilla, Javier Pagonabarraga, Saül Martínez-Horta, Berta Pascual-Sedano, Antonia Campolongo, Jaime Kulisevsky, Parkinson's disease-cognitive rating scale: Psychometrics for mild cognitive impairment, Movement Disorders, 2013, 28, 10
  26. 26
    Dinora A. Morales, Yolanda Vives-Gilabert, Beatriz Gómez-Ansón, Endika Bengoetxea, Pedro Larrañaga, Concha Bielza, Javier Pagonabarraga, Jaime Kulisevsky, Idoia Corcuera-Solano, Manuel Delfino, Predicting dementia development in Parkinson's disease using Bayesian network classifiers, Psychiatry Research: Neuroimaging, 2013, 213, 2, 92

    CrossRef

  27. 27
    Paulo Bugalho, Miguel Viana-Baptista, Predictors of Cognitive Decline in the Early Stages of Parkinson's Disease: A Brief Cognitive Assessment Longitudinal Study, Parkinson's Disease, 2013, 2013, 1

    CrossRef

  28. 28
    C. Villa-Bonomo, J. Pagonabarraga, S. Martínez-Horta, R. Fernandez de Bobadilla, C. Garcia-Sanchez, A. Campolongo, J. Kulisevsky, Short-lasting episodes of prosopagnosia in Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 3, 375

    CrossRef

  29. 29
    C. Tremblay, A. M. Achim, J. Macoir, L. Monetta, The heterogeneity of cognitive symptoms in Parkinson's disease: a meta-analysis, Journal of Neurology, Neurosurgery & Psychiatry, 2013, 84, 11, 1265

    CrossRef

  30. 30
    Peter McColgan, Jonathan R. Evans, David P. Breen, Sarah L. Mason, Roger A. Barker, Caroline H. Williams-Gray, Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease, Movement Disorders, 2012, 27, 9
  31. 31
    Jennifer G. Goldman, Holly Weis, Glenn Stebbins, Bryan Bernard, Christopher G. Goetz, Clinical differences among mild cognitive impairment subtypes in Parkinson's disease, Movement Disorders, 2012, 27, 9
  32. 32
    Maja Relja, Clinical rating scales, Parkinsonism & Related Disorders, 2012, 18, S229

    CrossRef

  33. 33
    Brandon Barton, David Grabli, Bryan Bernard, Virginie Czernecki, Jennifer G. Goldman, Glenn Stebbins, Bruno Dubois, Christopher G. Goetz, Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia, Movement Disorders, 2012, 27, 2
  34. 34
    Sarah L. Mason, Roger A. Barker, Cognitive Deficits in Early Parkinson’s Disease: New Areas of Research, Current Translational Geriatrics and Experimental Gerontology Reports, 2012, 1, 1, 39

    CrossRef

  35. 35
    Javier Pagonabarraga, Jaime Kulisevsky, Cognitive impairment and dementia in Parkinson's disease, Neurobiology of Disease, 2012, 46, 3, 590

    CrossRef

  36. 36
    Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster, Ben A. Schmand, Daniel Weintraub, Ronald C. Petersen, Brit Mollenhauer, Charles H. Adler, Karen Marder, Caroline H. Williams-Gray, Dag Aarsland, Jaime Kulisevsky, Maria C. Rodriguez-Oroz, David J. Burn, Roger A. Barker, Murat Emre, Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines, Movement Disorders, 2012, 27, 3
  37. 37
    David Garcia-Garcia, Pedro Clavero, Carmen Gasca Salas, Isabel Lamet, Javier Arbizu, Rafael Gonzalez-Redondo, Jose A. Obeso, Maria C. Rodriguez-Oroz, Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39, 11, 1767

    CrossRef

  38. 38
    Javier Pagonabarraga, Beatriz Gómez-Ansón, Ramon Rotger, Gisela Llebaria, Carmen García-Sánchez, Berta Pascual-Sedano, Alexandre Gironell, Manuel Delfino, Jaume Ruscalleda, Jaime Kulisevsky, Spectroscopic Changes Associated with Mild Cognitive Impairment and Dementia in Parkinson’s Disease, Dementia and Geriatric Cognitive Disorders, 2012, 34, 5-6, 312

    CrossRef

  39. 39
    Keith A. Hawkins, Danna Jennings, Andrea S. Vincent, Kirby Gilliland, Adrienne West, Kenneth Marek, Traditional neuropsychological correlates and reliability of the Automated Neuropsychological Assessment Metrics-4 battery for Parkinson’s disease, Parkinsonism & Related Disorders, 2012, 18, 7, 864

    CrossRef

  40. 40
    John C. Dalrymple-Alford, Leslie Livingston, Michael R. MacAskill, Charlotte Graham, Tracy R. Melzer, Richard J. Porter, Richard Watts, Tim J. Anderson, Characterizing mild cognitive impairment in Parkinson's disease, Movement Disorders, 2011, 26, 4
  41. 41
    Paolo Barone, Dag Aarsland, David Burn, Murat Emre, Jaime Kulisevsky, Daniel Weintraub, Cognitive impairment in nondemented Parkinson's disease, Movement Disorders, 2011, 26, 14
  42. 42
    J. Kulisevsky, J. Pagonabarraga, G. Llebaria, B. Hernández, J. Arranz, Evaluación de la satisfacción médico/paciente con el uso del “Parkinson's Disease Dementia-Short-Screen” (PDD-SS): un test de cribado para la demencia en la enfermedad de Parkinson (estudio DIFUSION), Neurología, 2011, 26, 8, 461

    CrossRef

  43. 43
    J. Kulisevsky, J. Pagonabarraga, G. Llebaria, B. Hernández, J. Arranz, Evaluation of doctor/patient satisfaction with the use of the Parkinson's Disease Dementia-Short-Screen (PDD-SS): a screening test for dementia in Parkinson's disease (DIFFUSION study), Neurología (English Edition), 2011, 26, 8, 461

    CrossRef

  44. 44
    Saül Martínez-Horta, Jaime Kulisevsky, Is all cognitive impairment in Parkinson’s disease “mild cognitive impairment”?, Journal of Neural Transmission, 2011, 118, 8, 1185

    CrossRef

  45. 45
    Irene Litvan, Dag Aarsland, Charles H. Adler, Jennifer G. Goldman, Jaime Kulisevsky, Brit Mollenhauer, Maria C. Rodriguez-Oroz, Alexander I. Tröster, Daniel Weintraub, MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI, Movement Disorders, 2011, 26, 10
  46. 46
    Dag Aarsland, Graciela Muniz, Fiona Matthews, Nonlinear decline of mini-mental state examination in Parkinson's disease, Movement Disorders, 2011, 26, 2
  47. You have free access to this content47
    John N. Caviness, LihFen Lue, Charles H. Adler, Douglas G. Walker, Parkinson's Disease Dementia and Potential Therapeutic Strategies, CNS Neuroscience & Therapeutics, 2011, 17, 1
  48. 48
    Daniel Weintraub, David J. Burn, Parkinson's disease: The quintessential neuropsychiatric disorder, Movement Disorders, 2011, 26, 6
  49. 49
    Dagmar Verbaan, Martine Jeukens-Visser, Teus Van Laar, Stephanie M. van Rooden, Erik W. Van Zwet, Johan Marinus, Jacobus J. van Hilten, SCOPA-cognition cutoff value for detection of Parkinson's disease dementia, Movement Disorders, 2011, 26, 10
  50. 50
    Kelvin L. Chou, Melissa M. Amick, Jason Brandt, Richard Camicioli, Karen Frei, Darren Gitelman, Jennifer Goldman, John Growdon, Howard I. Hurtig, Bonnie Levin, Irene Litvan, Laura Marsh, Tanya Simuni, Alexander I. Tröster, Ergun Y. Uc, A recommended scale for cognitive screening in clinical trials of Parkinson's disease, Movement Disorders, 2010, 25, 15
  51. 51
    Karen Marder, Cognitive impairment and dementia in Parkinson's disease, Movement Disorders, 2010, 25, S1
  52. 52
    Chiara Siri, Roberto Cilia, Danilo Gaspari, Margherita Canesi, Nicoletta Meucci, Anna Lena Zecchinelli, Gianni Pezzoli, Angelo Antonini, Cognitive status of patients with Parkinson’s disease and pathological gambling, Journal of Neurology, 2010, 257, 2, 247

    CrossRef

  53. 53
    Mark J. Millan, From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease, Pharmacology & Therapeutics, 2010, 128, 2, 229

    CrossRef

  54. 54
    Marcos Serrano-Dueñas, Belén Calero, Soledad Serrano, Maite Serrano, Paulina Coronel, Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease, Movement Disorders, 2010, 25, 15
  55. 55
    Gisela Llebaria, Javier Pagonabarraga, Mercè Martínez-Corral, Carmen García-Sánchez, Berta Pascual-Sedano, Alexandre Gironell, Jaime Kulisevsky, Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease, Movement Disorders, 2010, 25, 16
  56. 56
    Mary J. Docherty, David J. Burn, Parkinson’s Disease Dementia, Current Neurology and Neuroscience Reports, 2010, 10, 4, 292

    CrossRef

  57. 57
    Javier Pagonabarraga, Jaime Kulisevsky, Gisela Llebaria, Carmen García-Sánchez, Berta Pascual-Sedano, Mercè Martinez-Corral, Alexandre Gironell, PDD-Short Screen: A brief cognitive test for screening dementia in Parkinson's disease, Movement Disorders, 2010, 25, 4
  58. 58
    Sarah H. M. Robben, Monique J. M. Sleegers, Paul L. J. Dautzenberg, Floor S. van Bergen, Jan-Pieter ter Bruggen, Marcel G. M. Olde Rikkert, Pilot study of a three-step diagnostic pathway for young and old patients with Parkinson's disease dementia: screen, test and then diagnose, International Journal of Geriatric Psychiatry, 2010, 25, 3
  59. 59
    Angelo Antonini, Roberto Cilia, Behavioural Adverse Effects of Dopaminergic Treatments in Parkinsonʼs Disease, Drug Safety, 2009, 32, 6, 475

    CrossRef

  60. 60
    Jaime Kulisevsky, Javier Pagonabarraga, Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment, Movement Disorders, 2009, 24, 8
  61. 61
    C. H. Williams-Gray, J. R. Evans, A. Goris, T. Foltynie, M. Ban, T. W. Robbins, C. Brayne, B. S. Kolachana, D. R. Weinberger, S. J. Sawcer, R. A. Barker, The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort, Brain, 2009, 132, 11, 2958

    CrossRef